Home › PsychoGenics And The Alzheimer's Drug Discovery Foundation Announce A Risk-Sharing Partnership For Preclinical Studies
 

Keywords :   


PsychoGenics And The Alzheimer's Drug Discovery Foundation Announce A Risk-Sharing Partnership For Preclinical Studies

2016-02-03 03:43:39| drugdiscoveryonline Home Page

PsychoGenics Inc. and the Alzheimer's Drug Discovery Foundation (ADDF) announce a new partnership to bring PsychoGenics' validated Alzheimer's animal models and experimental services to ADDF grantees working on preclinical Alzheimer's drug discovery programs

Tags: studies foundation drug partnership

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
More »